The UK government announced on August 12, 2026 its intention to legislate on the role of artificial intelligence in gene synthesis, moving away from its current voluntary framework toward enforceable biosecurity rules. This legislation aims to address gaps in the current system, which requires no mandatory verification of customer identity or screening of ordered sequences. Providers would now be required to verify customer identities and check ordered sequences against databases of dangerous organisms and toxins. This initiative follows an open letter in June 2026 signed by prominent tech leaders including OpenAI CEO Sam Altman and Google DeepMind CEO Demis Hassabis, advocating for mandatory synthetic DNA screening safeguards.
Source: Read the original article
